HSBC Maintains Buy on Zoetis, Lowers Price Target to $225
Zoetis Analyst Ratings
HSBC Adjusts Price Target on Zoetis to $225 From $230
Zoetis Analyst Ratings
Piper Sandler Issues a Buy Rating on Zoetis (ZTS)
Goldman Sachs Adjusts Price Target on Zoetis to $196 From $223
Redburn Atlantic Adjusts Price Target on Zoetis to $220 From $230, Keeps Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
Zoetis Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Zoetis (ZTS)
Zoetis Analyst Ratings
Zoetis (ZTS) Gets a Buy From Bank of America Securities
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Zoetis (ZTS) and TScan Therapeutics (TCRX)
Zoetis Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Nyxoah (NYXH) and Zoetis (ZTS)
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
Zoetis Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC), Merck & Company (MRK) and Zoetis (ZTS)
Piper Sandler Raises Price Target on Zoetis to $220 From $215, Maintains Overweight Rating
Zoetis Analyst Ratings
No Data